Follow
Kai Kammers
Title
Cited by
Cited by
Year
Reproducible RNA-seq analysis using recount2
L Collado-Torres, A Nellore, K Kammers, SE Ellis, MA Taub, KD Hansen, ...
Nature biotechnology 35 (4), 319-321, 2017
3762017
Detecting Significant Changes in Protein Abundance.
K Kammers, RN Cole, C Tiengwe, I Ruczinski
EuPa Open Proteomics 7 (Jun), 11-19, 2015
2792015
Adjuvant radiotherapy of regional lymph nodes in breast cancer-a meta-analysis of randomized trials
W Budach, K Kammers, E Boelke, C Matuschek
Radiation Oncology 8, 1-7, 2013
1602013
Adjuvant radiation therapy of regional lymph nodes in breast cancer-a meta-analysis of randomized trials-an update
W Budach, E Bölke, K Kammers, PA Gerber, C Nestle-Krämling, ...
Radiation oncology 10, 1-7, 2015
1492015
Induction chemotherapy followed by concurrent radio-chemotherapy versus concurrent radio-chemotherapy alone as treatment of locally advanced squamous cell carcinoma of the head …
W Budach, E Bölke, K Kammers, PA Gerber, K Orth, S Gripp, C Matuschek
Radiotherapy and Oncology 118 (2), 238-243, 2016
1282016
The benefit of adjuvant radiotherapy after breast conserving surgery in older patients with low risk breast cancer-a meta-analysis of randomized trials
C Matuschek, E Bölke, J Haussmann, S Mohrmann, C Nestle-Krämling, ...
Radiation Oncology 12, 1-8, 2017
922017
Approach to family screening in arrhythmogenic right ventricular dysplasia/cardiomyopathy
ASJM Te Riele, CA James, JA Groeneweg, AC Sawant, K Kammers, ...
European heart journal 37 (9), 755-763, 2016
912016
Inverting the model of genomics data sharing with the NHGRI Genomic Data Science Analysis, Visualization, and Informatics Lab-space
MC Schatz, AA Philippakis, E Afgan, E Banks, VJ Carey, RJ Carroll, ...
Cell Genomics 2 (1), 2022
802022
Molecular biological determinations of meningioma progression and recurrence
S Linsler, D Kraemer, C Driess, J Oertel, K Kammers, J Rahnenführer, ...
PloS one 9 (4), e94987, 2014
742014
Targeting mitochondrial translation by inhibiting DDX3: a novel radiosensitization strategy for cancer treatment
MR Heerma van Voss, F Vesuna, GM Bol, J Afzal, S Tantravedi, ...
Oncogene 37 (1), 63-74, 2018
612018
RNA helicase DDX3: a novel therapeutic target in Ewing sarcoma
BA Wilky, C Kim, G McCarty, EA Montgomery, K Kammers, LR DeVine, ...
Oncogene 35 (20), 2574-2583, 2016
542016
p15 promoter methylation-a novel prognostic marker in glioblastoma patients
S Wemmert, M Bettscheider, S Alt, R Ketter, K Kammers, W Feiden, ...
International journal of oncology 34 (6), 1743-1748, 2009
452009
Standardized in vitro analysis of the degradability of hyaluronic acid fillers by hyaluronidase
BA Buhren, H Schrumpf, E Bölke, K Kammers, PA Gerber
European journal of medical research 23, 1-6, 2018
412018
Integrated omic analysis of a guinea pig model of heart failure and sudden cardiac death
DB Foster, T Liu, K Kammers, R O’Meally, N Yang, KN Papanicolaou, ...
Journal of proteome research 15 (9), 3009-3028, 2016
392016
Effects of Radiotherapy in the treatment of multiple myeloma: a retrospective analysis of a Single Institution
C Matuschek, TA Ochtrop, E Bölke, U Ganswindt, R Fenk, S Gripp, ...
Radiation Oncology 10, 1-9, 2015
382015
Quantitative proteomic analysis reveals similarities between Huntington’s disease (HD) and Huntington’s disease-like 2 (HDL2) human brains
T Ratovitski, R Chaerkady, K Kammers, JC Stewart, A Zavala, ...
Journal of proteome research 15 (9), 3266-3283, 2016
362016
Do insulin-like growth factor associated proteins qualify as a tumor marker? Results of a prospective study in 163 cancer patients
G Matuschek, M Rudoy, M Peiper, PA Gerber, NP Hoff, BA Buhren, ...
European journal of medical research 16, 451-456, 2011
332011
Survival models with preclustered gene groups as covariates
K Kammers, M Lang, JG Hengstler, M Schmidt, J Rahnenführer
BMC bioinformatics 12, 1-12, 2011
332011
Genome sequencing unveils a regulatory landscape of platelet reactivity
AR Keramati, MH Chen, BAT Rodriguez, LR Yanek, A Bhan, BJ Gaynor, ...
Nature communications 12 (1), 3626, 2021
302021
Progesterone receptor membrane component 1 (PGRMC1) binds and stabilizes cytochromes P450 through a heme-independent mechanism
MR McGuire, D Mukhopadhyay, SL Myers, EP Mosher, RT Brookheart, ...
Journal of Biological Chemistry 297 (5), 2021
282021
The system can't perform the operation now. Try again later.
Articles 1–20